Startups
Vibalogics is a full-service CDMO offering process technical transfer, development, GMP manufacturing, testing and fill-finish services to innovators developing virotherapies. Through a comprehensive set of clinical- and commercial-enabling service offerings, we partner with our clients to support early-to-late stage success. Built on a foundation of robust industry-leading scientific expertise, quality systems and global regulatory compliance, we deliver manufactured products with a complementing customer service experience that is customer friendly, communication-forward, transparent and flexible.
Service Offerings:
GMP Cell Banking | GMP Viral Banking | Technical Transfer | Process & Analytical Development | GMP Drug Substance Manufacture | GMP Drug Product Manufacture | Formulation, Fill & Finish | Lot / Batch Release | Stability Studies
Product Experience Includes:
Oncolytic Viruses | Viral Vectors | Vaccines | Adenovirus (Primate & Human) | Adeno-Associated (AAV) | Dengue | Herpes (HSV, Marek Disease, CMV) | Influenza (Flu) | Infectious Bursal Disease (IBDV) | Measles (Rubeola) | Newcastle Disease (NDV) | Porcine Reproductive Respiratory Syndrome (PRRSV) | Respiratory-Syncitial Virus (RSV) | Vaccinia (VACV/MVA)
Service Offerings:
GMP Cell Banking | GMP Viral Banking | Technical Transfer | Process & Analytical Development | GMP Drug Substance Manufacture | GMP Drug Product Manufacture | Formulation, Fill & Finish | Lot / Batch Release | Stability Studies
Product Experience Includes:
Oncolytic Viruses | Viral Vectors | Vaccines | Adenovirus (Primate & Human) | Adeno-Associated (AAV) | Dengue | Herpes (HSV, Marek Disease, CMV) | Influenza (Flu) | Infectious Bursal Disease (IBDV) | Measles (Rubeola) | Newcastle Disease (NDV) | Porcine Reproductive Respiratory Syndrome (PRRSV) | Respiratory-Syncitial Virus (RSV) | Vaccinia (VACV/MVA)
Overview
Location
United States, Massachusetts, Boxborough
Employees
51-200
Founded date
2002
Mentions in press and media 4
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Feb 18, 2022 | Recipharm expands its advanced therapy medicinal products (ATMPs) offering into Virotherapies with the acquisition of Vibalogics | Recipharm expands its advanced therapy medicinal products (ATMPs) offering into Virotherapies with the acquisition of Vibalogics Fri, Feb 18, 2022 08:00 CET Report this content Recipharm, a global contract development and manufacturing orga... |
| May 31, 2019 | Foursquare Buys Location Data Company Placed From Snap: Term Sheet | CHANGING LOCATION Good morning, Term Sheet readers — I’m back! Paid Content Securing the enterprise without boundaries From ExtraHop Foursquare plans to merge Placed with its own ad-effectiveness-measurement product and rebrand it as “Place... |
| May 30, 2019 | Ampersand Acquires Vibalogics | Vibalogics GmbH, a contract development and manufacturing organization (CDMO) focused on complex live biological products, is being acquired by Ampersand Capital Partners, a private equity firm specializing in growth equity investments in t... |
Reviews 0
FAQ about Vibalogics
When was Vibalogics founded?
Vibalogics was founded in 2002.
What has the press written about Vibalogics?
Parsers VC has collected 4 articles mentioning Vibalogics, among them “Recipharm expands its advanced therapy medicinal products (ATMPs) offering into Virotherapies with the acquisition of Vibalogics” (Feb 18, 2022) and “Foursquare Buys Location Data Company Placed From Snap: Term Sheet” (May 31, 2019).
Is Vibalogics still active?
Yes, Vibalogics is active; its latest activity on Parsers VC dates from Apr 11, 2022.